ImmunityBio, Inc. (IBRX)
7.92
-0.03
(-0.38%)
USD |
NASDAQ |
Sep 01, 12:00
ImmunityBio Cash from Operations (TTM) : -281.14M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -281.14M |
| March 31, 2026 | -294.39M |
| December 31, 2025 | -304.94M |
| September 30, 2025 | -319.70M |
| June 30, 2025 | -349.56M |
| March 31, 2025 | -370.16M |
| December 31, 2024 | -391.24M |
| September 30, 2024 | -421.36M |
| June 30, 2024 | -410.00M |
| March 31, 2024 | -389.43M |
| December 31, 2023 | -366.76M |
| September 30, 2023 | -342.21M |
| June 30, 2023 | -335.41M |
| March 31, 2023 | -346.89M |
| December 31, 2022 | -337.51M |
| September 30, 2022 | -318.42M |
| June 30, 2022 | -310.54M |
| March 31, 2022 | -288.88M |
| December 31, 2021 | -274.42M |
| September 30, 2021 | -225.84M |
| June 30, 2021 | -171.40M |
| March 31, 2021 | -118.33M |
| Date | Value |
|---|---|
| December 31, 2020 | -70.45M |
| September 30, 2020 | -62.28M |
| June 30, 2020 | -60.57M |
| March 31, 2020 | -60.88M |
| December 31, 2019 | -61.36M |
| September 30, 2019 | -60.51M |
| June 30, 2019 | -61.51M |
| March 31, 2019 | -60.95M |
| December 31, 2018 | -63.38M |
| September 30, 2018 | -62.99M |
| June 30, 2018 | -55.55M |
| March 31, 2018 | -54.23M |
| December 31, 2017 | -48.78M |
| September 30, 2017 | -45.89M |
| June 30, 2017 | -46.44M |
| March 31, 2017 | -39.79M |
| December 31, 2016 | -38.59M |
| September 30, 2016 | -38.92M |
| June 30, 2016 | -32.42M |
| March 31, 2016 | -32.26M |
| December 31, 2015 | -25.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Sarepta Therapeutics, Inc. | 93.95M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |